StockData
Stemtech Corp logo

Stemtech Corp (STEK) stock

STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $296.22KP/E –Yield –

Stemtech r&d expenses

Research and development expenses are spending on new products and technology.

Stemtech's R&D Expenses for the twelve months ending Sep 30, 2026 was $0. For fiscal 2025 it was $0.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$13.80K–
FY2022Dec 31, 2022$0–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Sep 30, 2026$0–
Q2 FY2026CQ2 2026Jun 30, 2026$0–
Q1 FY2026CQ1 2026Mar 31, 2026$0–
Q4 FY2025CQ4 2025Dec 31, 2025$0–
Q3 FY2025CQ3 2025Sep 30, 2025$0–
Q2 FY2025CQ2 2025Jun 30, 2025$0–
Q1 FY2025CQ1 2025Mar 31, 2025$0–
Q4 FY2024CQ4 2024Dec 31, 2024$0–
Q3 FY2024CQ3 2024Sep 30, 2024$0–
Q2 FY2024CQ2 2024Jun 30, 2024$0-100.0%
Q1 FY2024CQ1 2024Mar 31, 2024$0-100.0%
Q4 FY2023CQ4 2023Dec 31, 2023$0–
Q3 FY2023CQ3 2023Sep 30, 2023$0–
Q2 FY2023CQ2 2023Jun 30, 2023$177–
Q1 FY2023CQ1 2023Mar 31, 2023$13.80K–
Q4 FY2022CQ4 2022Dec 31, 2022$0–
Q3 FY2022CQ3 2022Sep 30, 2022$0–
Q2 FY2022CQ2 2022Jun 30, 2022$0–
Q1 FY2022CQ1 2022Mar 31, 2022$0–

More Stemtech figures

See a number that looks wrong?